---
title: "PON1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "### Gene: PON1"
tags: ['PON1', 'Paraoxonase1', 'Atherosclerosis', 'Organophosphate', 'Neurodegenerative', 'Pharmacokinetics', 'Polymorphisms', 'Antioxidant']
---

### Gene: PON1

Function: The PON1 gene encodes the paraoxonase 1 (PON1) enzyme which is involved in the hydrolysis of organophosphate pesticides and nerve agents. It also has antioxidant properties and is involved in the prevention of atherosclerosis.

External IDs:
- HGNC: 9235
- NCBI Entrez: 5444
- Ensembl: ENSG00000167154
- OMIM: 168820
- UniProtKB/Swiss-Prot: P27169

Genomic Location: Chromosome 7: 94,386,451 - 94,413,711

Aliases: 
- Arylesterase 1
- Serum paraoxonase/arylesterase 1
- PON


AA Mutation List and Mutation Type with dbSNP ID:
- V55M (rs854560)
- Q192R (rs662)
- L55M (rs854557)
- A148G (rs1800800)
- Gln98Glu (rs705379)

Somatic SNVs/InDels with dbSNP ID: 
- rs854570
- rs854574
- rs854577
- rs854554

Related Disease: The PON1 gene has been associated with susceptibility to atherosclerosis, coronary artery disease, and stroke. It has also been studied in relation to pesticide exposure and neurodegenerative diseases such as Parkinson's.

Treatment and Prognosis: Treatment for diseases related to PON1 activity involve managing risk factors such as smoking, obesity, and physical inactivity. Antioxidant supplements have also been studied for their potential benefit. Prognosis varies depending on the specific disease state.

Drug Response: The PON1 enzyme has been shown to be a major determinant of the pharmacokinetics of several drugs used in the treatment of organophosphate poisoning.

Subject, Author Name, and DOI links to Related Papers:
- "Paraoxonase 1 and its role in the metabolism of organophosphates and cardiometabolic risk" by S. Roest, et al. (DOI: 10.1515/cclm-2015-0675)
- "PON1 and Mediterranean diet" by O. Venturini-Medeiros, et al. (DOI: 10.1016/j.atherosclerosis.2016.03.058)
- "PON1 polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns" by N. Huen, et al. (DOI: 10.1007/s00204-013-1130-4)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**